On the 13th October we hosted a kidney cancer patient day in Sheffield with the help and support of the staff from Weston Park Hospital.

Thank you to the Uro-Oncology team at Weston Park Hospital and the speakers who on the day provided for patients presentations on a variety of related topics including managing side effects, treatments, patient stories, dietary advice and much more.

Thank you to the patients who joined us on the day, their feedback was excellent and we asked them to provide three words that described the day, some of the words they came back with included: Supportive, informative, inclusive, interesting, positive, reassuring, inspirational and moving....

When we work with excellent health care professionals and patients it shows we are are #StrongerTogether!
To find out more about our patient days please follow the link below:
https://actionkidneycancer.org/.../patient-information-days/

#bypatientsforpatients #kidneycancer

We would like to say a massive thank you to Joanna and Mikaela who completed on the 12th October the Bournemouth Supernova 5K run to raise funds for us.

We would like to thank their family and friends for donating to their funding raising.

If you would like to donate to their fundraising pages you can do so by following the links below:

https://kcsn.enthuse.com/pf/joanna-farr

https://kcsn.enthuse.com/pf/mikaela-hed

#kidneycancer #bypatientsforpatients #StrongerTogether

The kidney cancer clinic at Addenbrooke's Hospital in Cambridge is using a new microscope capable of diagnosing biopsy samples within minutes instead of days or weeks. This confocal microscope is the first to be used in this manner in the UK as a "one-stop" kidney clinic.

Read more on our website here:

On Tuesday the 7th October we hosted a kidney cancer patient day in Truro with the help and support of the staff from Royal Cornwall Trust.
On the day we had speakers on a range of related topics and patients had the opportunity to speak with each other and share their experience of living with kidney cancer.
Feedback echoed by many on the day included 'I felt the day was very informative, it was great to meet others in the same situation. I went away feeling happy!'
Thank you to the Uro-Oncology team at the Royal Cornwall Trust, the speakers and the patients who joined us for this great day.

We are #StrongerTogether!

To find out more about our patient days please follow the link below:
https://actionkidneycancer.org/help-support/patient-information-days/

#bypatientsforpatients

A new treatment called casdatifan showed promising responses in a phase 1 trial looking at the best dose to use for previously treatment patients with advanced kidney cancer. More than a third of patients responded to treatment, and the time to when the treatment stopped working and the cancer started growing again (progression-free survival) was a year, which is very promising in patients who are on their second, third, fourth or even fifth line of treatment.

Read more on our website here:

A promising new treatment for a hereditary form of kidney cancer:

A recent study has shown that a combination of an immunotherapy called bevacizumab and a TKI called erlotinib was highly effective in an hereditary form of papillary kidney cancer, called hereditary leiomyomatosis renal cell carcinoma (HLRCC)-associated papillary RCC.

Read more on our website here: